DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 158 filers reported holding DIPLOMAT PHARMACY INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2018 | $25,000 | 0.0% | 1,231 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $25,000 | -59.0% | 1,231 | -58.0% | 0.00% | -50.0% |
| Q3 2017 | $61,000 | +22.0% | 2,931 | -12.5% | 0.00% | 0.0% |
| Q2 2017 | $50,000 | -2.0% | 3,351 | +4.1% | 0.00% | 0.0% |
| Q1 2017 | $51,000 | +59.4% | 3,220 | +26.3% | 0.00% | 0.0% |
| Q4 2016 | $32,000 | +28.0% | 2,550 | +185.6% | 0.00% | +100.0% |
| Q3 2016 | $25,000 | +212.5% | 893 | +288.3% | 0.00% | – |
| Q2 2016 | $8,000 | -20.0% | 230 | -24.6% | 0.00% | -100.0% |
| Q4 2015 | $10,000 | – | 305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |